Vasopressin Injection, Solution
Product Images NDC 25021-474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vasopressin (NDC 25021-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Vas03 0000 01)

Structural Formula (Vas03 0000 01)
This information appears to be a chemical sequence or notation involving amino acids like cysteine, tyrosine, phenylalanine, glutamic acid, aspartic acid, proline, arginine, and glycine. The numbers likely correspond to specific positions or identifiers within the sequence.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Vas03 0000 02)

Package Label – Principal Display Panel – Vial Label (Vas03 0000 02)
This is a product label for Vasopressin Injection, USP with 20 Units per mL for intravenous infusion. It is a 1 mL Single-Dose Vial that must be diluted before use. The product is manufactured by SAGENT Pharmaceuticals in Schaumburg, IL, USA, and is made in India. The label includes a barcode, LOT/EXP information, and size specifications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.